As studies suggest that FFAR2 expression is reduced in certain cancers [30], and that proliferation may be inhibited by short chain fatty acids, butyrate and propionate [31, 43], we speculated that short chain fatty acid receptors might play a role in regulating breast cancer progression, and possibly metastasis. Here, FFAR2 is linked to breast carcinoma.